NSCLC Adjuvant Immunotherapy

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
06:48

Insights from ELCC 2025

ELCC 2025 Insights: PACIFIC Trial Analysis - Differential Effect of PPIs & Antibiotics on Clinical Outcomes From IO or Placebo in Stage 3 Unresectable NSCLC Patients Who Have Not Progressed Following CRT

FEATURING Leonardo Brunetti
  • 1 view
  • April 17, 2025
08:13

Insights from ELCC 2025

ELCC 2025 Insights: Phase 2 Study of Telomere-Targeting Agent THIO Sequenced by Cemiplimab in ICI-Resistant Advanced NSCLC - Interleukin-6 as a Potential Predictive Biomarker

FEATURING Tomasz Jankowski
  • April 17, 2025
13:14

Insights from ELCC 2025

ELCC 2025 Summary: Managing Locally Advanced NSCLC With Poor Lung Function - The Role of RT in the Era of IO

FEATURING Corinne Faivre-Finn
  • 3 views
  • April 11, 2025
09:09

Insights from ELCC 2025

ELCC 2025 Insights: Is SBRT + IO New SoC for Early NSCLC?

FEATURING Andrea Filippi
  • 7 views
  • April 8, 2025
88:26

The Immuno-Oncology Clinical Network (IOCN)

Immune Checkpoint Inhibitors in Advanced NSCLC & Metastatic Melanoma Cases: A Focus on Triple M Syndrome - Panel Discussion

FEATURING Anna Olsson-Brown, Adam Chapman, Clare Barlow, Aisling Carr, Ricky Frazer
  • 12 views
  • March 21, 2025
06:35

Johns Hopkins

Role of Personalized Neoantigen Vaccines in Melanoma and NSCLC

FEATURING Aliyah Pabani
  • 44 views
  • March 17, 2025
11:35

Total Health

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

FEATURING David Carbone
  • 219 views
  • March 8, 2025
  • 1
04:18

Total Health

Preoperative TKIs in Neoadjuvant NSCLC

FEATURING David Carbone
  • 69 views
  • March 8, 2025
41:10

UCLA Health

Unmet Treatment Needs of Chemo-IO in Resectable NSCLC

FEATURING Jay M. Lee
  • 64 views
  • March 8, 2025
31:15

UCLA Health

Current Landscape of Neoadjuvant, Perioperative, and Adjuvant IO in Resectable NSCLC

FEATURING Jay M. Lee
  • 132 views
  • March 8, 2025
  • 2
04:51

GRACE

The Future of Lung Cancer Treatment: What’s on the Horizon?

FEATURING Julia Rotow, Ibiayi Dagogo-Jack, Misty Shields, Alissa Cooper, Angel Qin
  • 93 views
  • February 24, 2025
48:32

The Immuno-Oncology Clinical Network (IOCN)

Case Studies and Q&A on Immune-Related Skin Toxicities Across Various Cancer Types

FEATURING Alexandra Johnson, Elaine Hindle, Trudy Guinan, Anna Olsson-Brown, Ricky Frazer
  • 9 views
  • January 22, 2025
28:21

Memorial Sloan Kettering Cancer Center

Role of Surgery in Locally Advanced NSCLC

FEATURING Katherine Gray
  • 278 views
  • January 17, 2025
  • 4
36:44

The Immuno-Oncology Clinical Network (IOCN)

Case Studies and Panel Discussion of Immune-Related Skin Toxicities Across Various Cancer Types

FEATURING Alexandra Johnson, Ricky Frazer, Elaine Hindle, Trudy Guinan, Anna Olsson-Brown
  • 15 views
  • January 14, 2025
04:02

Yale Cancer Center

Resectable NSCLC: Perioperative Immunotherapy and Multidisciplinary Care

FEATURING Gavitt Woodard
  • 87 views
  • January 14, 2025
07:20

Yale Cancer Center

Key Advances in Lung Cancer Therapies: A Comprehensive Overview

FEATURING Anne Chiang
  • 88 views
  • January 14, 2025
09:53

Nebraska Oncology Society

Year in Review 2024 - Perioperative Immunotherapy in Resectable NSCLC

FEATURING Joseph Murray
  • 69 views
  • January 5, 2025
  • 1
31:31

University of Illinois Cancer Center

Navigating Neoadjuvant Options for Early Stage Lung Cancer: Current Updates in the Perioperative Treatment

FEATURING Frank Weinberg
  • 69 views
  • December 5, 2024
  • 2
31:14

Oncology 2024 Year in Review

Year in Review 2024 - NSCLC Perioperative Therapy

FEATURING Balazs Halmos
  • 1,022 views
  • December 2, 2024
  • 16
10:17

Total Health

Treatment Updates in Early Stage NSCLC - Advances in Thoracic Oncology

FEATURING Jason Porter
  • 205 views
  • October 29, 2024
  • 3
17:26

Springer Healthcare IME

Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion

FEATURING Jaime Schneider, Solange Peters, Lizza Hendriks
  • 93 views
  • October 29, 2024
  • 1
11:14

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: CCTG BR.31 - Adjuvant Durvalumab in Completely Resected NSCLC

FEATURING Glenwood Goss
  • 23 views
  • October 21, 2024
10:25

Yale Cancer Center

Key NSCLC Trial Updates Including ADAURA and KEYNOTE-671

FEATURING Sarah Goldberg
  • 89 views
  • October 21, 2024
  • 1
14:17

Insights from 2024 WCLC

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Therapy Debate in NSCLC

FEATURING Jan Von Der Thusen
  • 282 views
  • October 21, 2024
  • 6
15:06

Federico Cappuzzo

Current & Future Directions of IO in Early Stage NSCLC

  • 123 views
  • October 17, 2024
  • 1

NSCLC Adjuvant Immunotherapy

No subtopics